- Home
- ACB
as 12-18-2024 11:30am EST
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
| Founded: | 2013 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 255.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 695.9K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.84 - $9.35 | Next Earning Date: | 02-06-2025 |
| Revenue: | $219,835,671 | Revenue Growth: | 13.15% |
| Revenue Growth (this year): | 22.14% | Revenue Growth (next year): | 7.12% |
Latest Aurora Cannabis Inc. News
ACB Breaking Stock News: Dive into ACB Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Aurora Cannabis Announces Distribution Partnership for Medical Cannabis Products in Australia
CNW Group
a day ago
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect
Insider Monkey
2 days ago
Why Aurora Cannabis (ACB) Is Among the Best Cannabis Stocks To Invest In?
CNW Group
22 days ago
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
CNW Group
a month ago
Aurora Cannabis Expands Innovative Recreational Product Portfolio
Morningstar Research
a month ago
Analyst Report: Aurora Cannabis Inc.
Morningstar Research
a month ago
Analyst Report: Aurora Cannabis Inc.
Simply Wall St.
a month ago
Aurora Cannabis Second Quarter 2025 Earnings: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)
Compare ACB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACB Aurora Cannabis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.